Precancerous conditions of the eye

Last medical review:

Precancerous conditions of the eye are changes to cells in the eye that make them more likely to develop into cancer. These conditions are not yet cancer. But if they are not treated, there is a chance that these changes will become eye cancer.

Primary acquired melanosis

Primary acquired melanosis (PAM) is the most common precancerous condition of the eye. It is caused by an overgrowth of the cells that make melanin( called melanocytes) in the conjunctiva. The extra melanocytes cause flat, brown patches that are irregularly shaped. The patches are usually seen in parts of the conjunctiva that overlay the sclera.

To diagnose PAM, your doctor will do an eye exam. You may also have a biopsy to check whether any of the extra melanocytes have changed to become abnormal. If any cells are abnormal, this is called PAM with atypia. PAM with atypia is more likely to develop into cancer.

Treatments

PAM that affects 1/4 of the eye or less can be treated with active surveillance. You will have other treatment if anything changes.

If you’re diagnosed with PAM in a large area of the conjunctiva or PAM with atypia, treatment options include:

  • topical chemotherapy with mitomycin C
  • surgery
  • cryosurgery

Conjunctival intraepithelial neoplasia

Conjunctival intraepithelial neoplasia (CIN) develops when squamous cells of the conjunctiva change and become abnormal. These changes may also be called dysplasia. Although CIN is not cancer, it can develop into a type of eye cancer called squamous cell carcinoma (SCC) of the conjunctiva if it’s not treated.

CIN is graded from 1 to 3 based on how much of the conjunctiva contains abnormal cells. It may also be described as mild, moderate or severe.

Grade 1 is also called mild CIN. Abnormal cells are found in 1/3 or less of the layers of the conjunctiva. It usually affects the part of the conjunctiva closest to the cornea.

Grade 2 is also called moderate CIN. Abnormal cells are found in about 2/3 of the layers of the conjunctiva.

Grade 3 is also called severe CIN. Almost all layers of the conjunctiva are affected, but abnormal cells have not yet made it to the layer of connective tissue.

CIN often appears as a white, greyish or yellowy piece of thick but see-through tissue on the surface of the conjunctiva. Your eye may also be red and irritated.

To diagnose CIN, your doctor will do an eye exam that may include ocular coherence tomography (OCT) or fluorescent angiography. You will also likely have a biopsy of the affected area. Find out more about these tests in diagnosis of eye cancer.

Treatments

Your healthcare team will consider things like the grade when deciding how to treat conjunctival intraepithelial neoplasia. Treatment options for CIN include:

  • surgery, with or without cryosurgery on the margins
  • topical chemotherapy with mytomycin C or fluorouracil

Expert review and references

  • Tina Felfeli, MD
  • Cancer Research UK. What is Eye Cancer. 2021. https://www.cancerresearchuk.org/.
  • Chang V, Bunya VY, Wells J, Engelmann A, Gurnani B. Ocular surface squamous neoplasia. EyeWiki. American Academy of Opthalmology; 2023. https://eyewiki.aao.org/Main_Page.
  • Choudhary MM, Singh AD. Ophthalmic cancers. Raghavan D, Ahluwalia MS, Blanke CD, et al, eds.. Textbook of Uncommon Cancers. 5th ed. Hoboken, NJ: Wiley Blackwell; 2017: Kindle version chapter 68 https://read.amazon.ca/?asin=B06XKD44V3&_encoding=UTF8&ref=dbs_p_ebk_r00_pbcb_rnvc00.
  • Cohen VML, O'Day RF. Management issues in conjunctival tumours: Conjunctival melanoma and primary acquired melanosis. Ophthalmology and Therapy. 2019: 8(4): 501–510.
  • Gurnani B, Kaur K. Ocular surface squamous neoplasia. StatPearls [Internet]. StatPearls Publishing; 2023.
  • Jakobiec FA. Conjunctival primary acquired melanosis: Is it time for a new terminology?. American Journal of Ophthalmology. 2016: 162:3–19.e1.
  • Kao A, Afshar A, Bloomer M, Damato B. Management of primary acquired melanosis, nevus, and conjunctival melanoma. Cancer Control. 2016: 23(2): 117–125.
  • Kelley S. Primary acquired melanosis (PAM): Symptoms, causes, and treatment. All About Vision. 2023.
  • Kiran NF, Mendoza P. Conjunctival Intraepithelial Neoplasia. PathologyOutlines.com; 2022. https://www.pathologyoutlines.com.
  • Svedburg K. Recurrence of primary acquired melanosis and conjunctival intraepithelial neoplasia. Ocular Oncology and Pathology. 2022: 8(4–6): 236–241.
  • Tanna AP. Chapter 12: Clinical Approach to Neoplastic Disorders of the Conjunctiva and Cornea – Tumors of Neuroectodermal Origin. 2020–2021 BCSC Basic and Clinical Science Course™. San Fransisco, CA: American Academy of Ophthalmology; 2020: Section 10.

Your trusted source for accurate cancer information

With just $5 from readers like you, we can continue to provide the highest quality cancer information for over 100 types of cancer.

We’re here to ensure easy access to accurate cancer information for you and the millions of people who visit this website every year. But we can’t do it alone.

If everyone reading this gave just $5, we could achieve our goal this month to fund reliable cancer information, compassionate support services and the most promising research. Please give today because every contribution counts. Thank you.

Medical disclaimer

The information that the Canadian Cancer Society provides does not replace your relationship with your doctor. The information is for your general use, so be sure to talk to a qualified healthcare professional before making medical decisions or if you have questions about your health.

We do our best to make sure that the information we provide is accurate and reliable but cannot guarantee that it is error-free or complete.

The Canadian Cancer Society is not responsible for the quality of the information or services provided by other organizations and mentioned on cancer.ca, nor do we endorse any service, product, treatment or therapy.


1-888-939-3333 | cancer.ca | © 2025 Canadian Cancer Society